Results 11 to 20 of about 8,915,614 (369)

Public toilets with insufficient ventilation present high cross infection risk. [PDF]

open access: yesSci Rep, 2021
Due to insufficient ventilation, public toilets present high risks for cross-infection. The study investigated 61 public toilets to identify the causes and locations of biological contaminated sources. Airborne and surface bacterial contamination, carbon
Lee MCJ, Tham KW.
europepmc   +2 more sources

Evaluation of Patient's Knowledge, Attitude, and Practice of Cross-Infection Control in Dentistry during COVID-19 Pandemic. [PDF]

open access: yesEur J Dent, 2020
Objectives The aim of this study was to evaluate the patient’s knowledge, attitude, and practice of cross-infection control in dentistry during coronavirus diseases 2019 (COVID-19).
Ahmed MA   +5 more
europepmc   +2 more sources

Stochastic modeling of the Monkeypox 2022 epidemic with cross-infection hypothesis in a highly disturbed environment.

open access: yesMathematical biosciences and engineering : MBE, 2022
Monkeypox 2022, a new re-emerging disease, is caused by the Monkeypox virus. Structurally, this virus is related to the smallpox virus and infects the host in a similar way; however, the symptoms of Monkeypox are more severe.
Asad Khan, Y. Sabbar, Anwarud Din
semanticscholar   +1 more source

The Risk of Cross Infection in the Emergency Department: A Simulation Study. [PDF]

open access: yesInfect Control Hosp Epidemiol, 2018
OBJECTIVES The risk of cross infection in a busy emergency department (ED) is a serious public health concern, especially in times of pandemic threats.
Hertzberg VS   +3 more
europepmc   +2 more sources

Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts

open access: yesNature Communications, 2022
Cross-reactive immune responses to SARS-CoV-2 have been observed in pre-pandemic cohorts and proposed to contribute to host protection. Here we assess 52 COVID-19 household contacts to capture immune responses at the earliest timepoints after SARS-CoV-2 ...
R. Kundu   +22 more
semanticscholar   +1 more source

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection

open access: yesScience, 2021
Boosterism could save lives Postinfection immune protection against severe acute respiratory syndrome coronavirus 2 reinfection is not fully understood.
L. Stamatatos   +18 more
semanticscholar   +1 more source

Knowledge, Attitudes, and Practices of Dental Patients Toward Cross-Infection and Economic Implications in View of Covid-19: An Online Survey

open access: yesJournal of Advanced Oral Research, 2020
Aim: To assess the knowledge, attitude, and practices of the patients regarding cross-infection in dental clinics in view of COVID-19, and its economic implications.
Rhythm Bains   +3 more
semanticscholar   +1 more source

Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation

open access: yesJournal of Medical Virology, 2020
There is currently very limited information on the nature and prevalence of post‐COVID‐19 symptoms after hospital discharge.
S. Halpin   +12 more
semanticscholar   +1 more source

Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes

open access: yesScience immunology, 2022
Omicron is the evolutionarily most distinct severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC) to date. We report that Omicron BA.1 breakthrough infection in BNT162b2-vaccinated individuals resulted in strong ...
Jasmin Quandt   +17 more
semanticscholar   +1 more source

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses

open access: yesNature reviews. Immunology, 2022
Pre-existing cross-reactive immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins in infection-naive subjects have been described by several studies.
Sam M. Murray   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy